Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{199942,
        author = {Dr. Akshita and Dr.Abhishek Bhushan Sharma},
        title = {Bridging Ayurveda and Modern Hepatology: A Comprehensive Review on Bhumyamalaki and Shyonaka in Chronic Hepatitis B Management},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {12},
        pages = {1810-1816},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=199942},
        abstract = {Chronic Hepatitis B (CHB) remains a major global health challenge, often leading to cirrhosis and hepatocellular carcinoma despite advances in antiviral therapy. Limitations such as long-term drug dependence, resistance, and incomplete viral clearance necessitate exploration of complementary approaches. Ayurveda, with its holistic understanding of liver disorders under the spectrum of Yakrit Vikara, offers promising therapeutic insights. This review aims to bridge traditional knowledge with modern hepatology by evaluating the role of Bhumyamalaki (Phyllanthus niruri) and Shyonaka (Oroxylum indicum) in CHB management Bhumyamalaki, described as a potent Pittashamaka and Yakrit-Uttejaka, exhibits significant antiviral and hepatoprotective properties, including inhibition of viral replication and improvement in liver enzyme profiles. Shyonaka, an important component of Dashamoola, demonstrates anti-inflammatory and tissue-protective effects, contributing to the restoration of Dhatu Samyata. From an Ayurvedic perspective, these drugs act through Agni Deepana, Ama Pachana, and Srotoshodhana, addressing the root pathology rather than symptomatic suppression Modern studies support their role in modulating immune responses, reducing oxidative stress, and enhancing hepatic regeneration. When used as adjuncts to standard antiviral therapy, they may improve therapeutic outcomes and reduce disease progression. However, high-quality clinical trials and standardized protocols are still required.This integrative review highlights the potential of combining Ayurvedic principles with contemporary medicine to develop safer, cost-effective, and patient-centric strategies for CHB management.},
        keywords = {Yakrit Vikara, Bhumyamalaki, Shyonaka, Agni, Ama, Shyonaka},
        month = {May},
        }